Online Only Articles

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

Pediatric Oncology, University Children’s Hospital Zurich, Switzerland
Department of Pediatric Haemato-Oncology, IRCCS Ospedale Bambino Gesù, Sapienza University of Rome, Italy
Haematology and Oncology Department, Great Ormond Street Hospital, London, UK
Pediatric Oncology, University Children’s Hospital Zurich, Switzerland
Department of Pediatric Hematology, Hôpital Robert Debré, Assistance Publique – Hôpitaux de Paris, France
Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany
Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany
Pediatric Hematology-Oncology, Schneider Children’s Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey
Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany
Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany
Bone Marrow Transplant Unit, Schneider Children’s Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
Haematology and Oncology Department, Great Ormond Street Hospital, London, UK
Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey
Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany;Pediatrics, Christian Albrechts University Kiel, University Medical Center, Kiel, Germany
Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey
Pediatric Oncology, University Children’s Hospital Zurich, Switzerland;Department of Pediatric Hematology, Hôpital Robert Debré, Assistance Publique – Hôpitaux de Paris, France
Department of Pediatric Haemato-Oncology, IRCCS Ospedale Bambino Gesù, Sapienza University of Rome, Italy
Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany
Pediatric Hematology and Oncology, Hannover Medical School, Germany
Pediatric Oncology, University Children’s Hospital Zurich, Switzerland
Vol. 104 No. 6 (2019): June, 2019 https://doi.org/10.3324/haematol.2018.210104